Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
First Course Treatment	STARTED	Sequence A, Drug: Everolimus First	72
First Course Treatment	STARTED	Sequence B, Drug: STZ - 5FU First	69
First Course Treatment	COMPLETED	Sequence A, Drug: Everolimus First	36
First Course Treatment	COMPLETED	Sequence B, Drug: STZ - 5FU First	33
First Course Treatment	NOT COMPLETED	Sequence A, Drug: Everolimus First	36
First Course Treatment	NOT COMPLETED	Sequence B, Drug: STZ - 5FU First	36
Second Course Treatment	STARTED	Sequence A, Drug: Everolimus First	36
Second Course Treatment	STARTED	Sequence B, Drug: STZ - 5FU First	33
Second Course Treatment	COMPLETED	Sequence A, Drug: Everolimus First	36
Second Course Treatment	COMPLETED	Sequence B, Drug: STZ - 5FU First	33
Second Course Treatment	NOT COMPLETED	Sequence A, Drug: Everolimus First	0
Second Course Treatment	NOT COMPLETED	Sequence B, Drug: STZ - 5FU First	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02246127/flow